Biopharmx reports third-quarter loss per share of 14 cents

Biopharmx reports fiscal third quarter 2020 financial results and provides corporate update.q3 non-gaap loss per share $0.13 excluding items.q3 loss per share $0.14.
TMBR Ratings Summary
TMBR Quant Ranking